OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features
Giovanni Monteleone, A. Moscardelli, Alice Colella, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 10, pp. 103410-103410
Open Access | Times Cited: 33
Giovanni Monteleone, A. Moscardelli, Alice Colella, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 10, pp. 103410-103410
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis
Virginia Solitano, Vipul Jairath, Federica Ungaro, et al.
Med (2024) Vol. 5, Iss. 5, pp. 386-400
Closed Access | Times Cited: 9
Virginia Solitano, Vipul Jairath, Federica Ungaro, et al.
Med (2024) Vol. 5, Iss. 5, pp. 386-400
Closed Access | Times Cited: 9
Exploring the Benefits and Prescribing Informations of Combining East Asian Herbal Medicine with Conventional Medicine in the Treatment of Rheumatoid Arthritis: A Systematic Review and Multifaceted Analysis of 415 Randomized Controlled Trials
Hee-Geun Jo, Jihye Seo, Eunhye Baek, et al.
Pharmacological Research (2025), pp. 107616-107616
Open Access
Hee-Geun Jo, Jihye Seo, Eunhye Baek, et al.
Pharmacological Research (2025), pp. 107616-107616
Open Access
Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events
Mark Lebwohl, Atul Deodhar, Sergio Schwartzman, et al.
Dermatology and Therapy (2025)
Open Access
Mark Lebwohl, Atul Deodhar, Sergio Schwartzman, et al.
Dermatology and Therapy (2025)
Open Access
Mesoporous polymeric nanoparticles for effective treatment of inflammatory diseases: an in vivo study
Divya Pareek, Md. Zeyaullah, Sukanya Patra, et al.
Journal of Materials Chemistry B (2025)
Closed Access
Divya Pareek, Md. Zeyaullah, Sukanya Patra, et al.
Journal of Materials Chemistry B (2025)
Closed Access
Specific Composition Diets and Improvement of Symptoms of Immune-Mediated Inflammatory Diseases in Adulthood—Could the Comparison Between Diets Be Improved?
María Dolores Guerrero Aznar, M Dolores Villanueva Guerrero, Margarita Beltrán García, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 493-493
Open Access
María Dolores Guerrero Aznar, M Dolores Villanueva Guerrero, Margarita Beltrán García, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 493-493
Open Access
Disease Acceptance and Control from the Subjective Health Experience Model as Health Perception Predictors in Immune-Mediated Inflammatory Diseases
Tessa S. Folkertsma, Sjaak Bloem, Robert M. Vodegel, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 538-538
Open Access
Tessa S. Folkertsma, Sjaak Bloem, Robert M. Vodegel, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 538-538
Open Access
TANK-Binding Kinase 1 in the Pathogenesis and Treatment of Inflammation-Related Diseases
Hui Lü, Xiaolin Chen, Mengke Huang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1941-1941
Open Access
Hui Lü, Xiaolin Chen, Mengke Huang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1941-1941
Open Access
Trend analysis and cross-national inequity analysis of immune-mediated inflammatory diseases in children and adolescents aged 10–24 from 1990 to 2021
Hailin Xu, Xiaofeng Liang, Ke Li, et al.
World Allergy Organization Journal (2025) Vol. 18, Iss. 3, pp. 101033-101033
Open Access
Hailin Xu, Xiaofeng Liang, Ke Li, et al.
World Allergy Organization Journal (2025) Vol. 18, Iss. 3, pp. 101033-101033
Open Access
Mendelian randomization-based observational cohort study on drug targets: Impact of antihypertensive and lipid-lowering therapies on inflammatory cytokines
Jingping Xin, Zhibin Xu, Feng Zhang, et al.
Medicine (2025) Vol. 104, Iss. 10, pp. e41771-e41771
Open Access
Jingping Xin, Zhibin Xu, Feng Zhang, et al.
Medicine (2025) Vol. 104, Iss. 10, pp. e41771-e41771
Open Access
Marine-Derived Alternariol Suppresses Inflammation by Regulating T Cell Activation and Migration
Chenfeng Liu, Fudie Gu, Zheng‐Biao Zou, et al.
Marine Drugs (2025) Vol. 23, Iss. 3, pp. 133-133
Open Access
Chenfeng Liu, Fudie Gu, Zheng‐Biao Zou, et al.
Marine Drugs (2025) Vol. 23, Iss. 3, pp. 133-133
Open Access
Mycobiota and Antifungal Antibodies as Emerging Targets for the Diagnosis and Prognosis of Human Diseases
Eguzkiñe Díez-Martín, Leidi Hernández-Suárez, Egoitz Astigarraga, et al.
Journal of Fungi (2025) Vol. 11, Iss. 4, pp. 296-296
Open Access
Eguzkiñe Díez-Martín, Leidi Hernández-Suárez, Egoitz Astigarraga, et al.
Journal of Fungi (2025) Vol. 11, Iss. 4, pp. 296-296
Open Access
Targeting vascular adhesion protein-1 and myeloperoxidase with a dual inhibitor SNT-8370 in preclinical models of inflammatory disease
Elias N. Glaros, Jonathan S. Foot, Ben Rayner, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Elias N. Glaros, Jonathan S. Foot, Ben Rayner, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Persea americana Peel: A Promising Source of Nutraceutical for the Mitigation of Cardiovascular Risk in Arthritic Rats Through the Gut–Joint Axis
Doha A. Mohamed, Asmaa Ramadan, Hoda B. Mabrok, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 590-590
Open Access
Doha A. Mohamed, Asmaa Ramadan, Hoda B. Mabrok, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 590-590
Open Access
Fine-tuning licensing strategies to boost MSC-based immunomodulatory secretome
Maria Rossello-Gelabert, Manoli Igartúa, Edorta Santos‐Vizcaíno, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Maria Rossello-Gelabert, Manoli Igartúa, Edorta Santos‐Vizcaíno, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Integrated Network Pharmacology and Experimental Approach to Investigate the Protective Effect of Jin Gu Lian Capsule on Rheumatoid Arthritis by Inhibiting Inflammation via IL-17/NF-κB Pathway
Tengfei Chen, Sihan Li, Dongyin Lian, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 3723-3748
Open Access | Times Cited: 8
Tengfei Chen, Sihan Li, Dongyin Lian, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 3723-3748
Open Access | Times Cited: 8
Investigation of the Causal Relationship Between Autoimmune Diseases and Premature Ovarian Insufficiency
Tingyu Lang, Shaoqi Hua, Junhong Du, et al.
Reproductive Sciences (2024)
Closed Access | Times Cited: 2
Tingyu Lang, Shaoqi Hua, Junhong Du, et al.
Reproductive Sciences (2024)
Closed Access | Times Cited: 2
Colon delivery of resveratrol for the treatment of inflammatory bowel disease
Hossein Shahdadi Sardou, Paria Rahnama Vosough, Mohammadreza Abbaspour, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 92, pp. 105315-105315
Closed Access | Times Cited: 5
Hossein Shahdadi Sardou, Paria Rahnama Vosough, Mohammadreza Abbaspour, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 92, pp. 105315-105315
Closed Access | Times Cited: 5
Leveraging Multi-tissue, Single-Cell Atlases as Tools to Elucidate Shared Mechanisms of Immune-Mediated Inflammatory Diseases
Anthony K. McLean, Gary Reynolds, Arthur G. Pratt
(2024)
Open Access | Times Cited: 1
Anthony K. McLean, Gary Reynolds, Arthur G. Pratt
(2024)
Open Access | Times Cited: 1
The shared role of neutrophils in ankylosing spondylitis and ulcerative colitis
Tianyou Chen, Weiming Tan, Xinli Zhan, et al.
Genes and Immunity (2024) Vol. 25, Iss. 4, pp. 324-335
Closed Access | Times Cited: 1
Tianyou Chen, Weiming Tan, Xinli Zhan, et al.
Genes and Immunity (2024) Vol. 25, Iss. 4, pp. 324-335
Closed Access | Times Cited: 1
Immune-Mediated Inflammatory Diseases and Cancer - a dangerous liaison
Jeanette A.M. Maier, Sara Castiglioni, Alessandra Petrelli, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Jeanette A.M. Maier, Sara Castiglioni, Alessandra Petrelli, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
CXCL13: a common target for immune-mediated inflammatory diseases
Hui Lü, Ye Li, Meng-ke Huang, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Hui Lü, Ye Li, Meng-ke Huang, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Sarcopenia and immune-mediated inflammatory diseases: Evaluating causality and exploring therapeutic targets for sarcopenia through Mendelian randomization
Qijun Wang, Xuan Zhao, Shuai-Kang Wang, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113687-113687
Open Access | Times Cited: 1
Qijun Wang, Xuan Zhao, Shuai-Kang Wang, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113687-113687
Open Access | Times Cited: 1
Modulation of Il-6 Receptor/Stat3 Downstream Signaling in Rheumatoid Arthritis Patients
Fabio Cacciapaglia, Simone Perniola, Stefano Stano, et al.
(2024)
Closed Access
Fabio Cacciapaglia, Simone Perniola, Stefano Stano, et al.
(2024)
Closed Access
Leveraging Multi-tissue, Single-Cell Atlases as Tools to Elucidate Shared Mechanisms of Immune-Mediated Inflammatory Diseases
Anthony K. McLean, Gary Reynolds, Arthur G. Pratt
(2024)
Open Access
Anthony K. McLean, Gary Reynolds, Arthur G. Pratt
(2024)
Open Access
Leveraging Multi-Tissue, Single-Cell Atlases as Tools to Elucidate Shared Mechanisms of Immune-Mediated Inflammatory Diseases
Anthony K. McLean, Gary Reynolds, Arthur G. Pratt
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1297-1297
Open Access
Anthony K. McLean, Gary Reynolds, Arthur G. Pratt
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1297-1297
Open Access
